# EVMN (Evommune, Inc.) - SEC EDGAR Financial Statements

> Evommune, Inc. reported $0 in revenue and a net loss of $113.1M for the trailing twelve months ended September 30, 2026 (down 100.0% year over year).

- Canonical: https://convexityos.com/fundamentals/EVMN
- Markdown: https://convexityos.com/fundamentals/EVMN.md
- SEC CIK: 0002044725
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:41 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0002044725&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $0 | -100.0% YoY |
| Operating Income | TTM | -$121.9M | Operating profit |
| Net Income | TTM | -$113.1M | GAAP bottom line |
| Diluted EPS | TTM | -$3.11 | Split-adjusted |
| Free Cash Flow | TTM | -$91.00M | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $168.6M | Total debt: $8.19M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 |
| --- | --- | --- |
| **Revenue** | $13.00M | $7.00M |
| Research & Development | $74.04M | $64.24M |
| Total Operating Expenses | $94.07M | $77.01M |
| **Operating Income** | -$81.07M | -$70.01M |
| **EBITDA** | -$80.47M | -$69.51M |
| Interest Income | $3.32M | $3.24M |
| Income Before Tax | -$68.87M | -$68.31M |
| Income Tax Expense | $0 | $0 |
| **Net Income** | -$68.87M | -$66.81M |
| Basic EPS | -$11.22 | -$45.29 |
| **Diluted EPS** | -$11.22 | -$45.29 |
| Basic Shares Outstanding | 6.1M | 1.5M |
| Diluted Shares Outstanding | 6.1M | 1.5M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Sep 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $0 | $0 | $0 | $0 | $10.00M | $0 | $3.00M | -- |
| Research & Development | $24.55M | $26.41M | $17.32M | $20.40M | $19.64M | $19.64M | $14.36M | $13.29M |
| Total Operating Expenses | $33.33M | $34.90M | $23.95M | $29.72M | $23.33M | $22.99M | $18.03M | $16.52M |
| **Operating Income** | -$33.33M | -$34.90M | -$23.95M | -$29.72M | -$13.33M | -$22.99M | -$15.03M | -$16.52M |
| **EBITDA** | -$33.13M | -$34.70M | -$23.85M | -$29.62M | -$13.23M | -$22.79M | -$14.83M | -- |
| Interest Income | $2.48M | $2.65M | $2.28M | $1.44M | $862K | $403K | $613K | $618K |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| **Net Income** | -$30.88M | -$32.25M | -$21.67M | -$28.27M | -$12.47M | -$13.56M | -$14.56M | -$15.92M |
| Basic EPS | -$0.85 | -$0.89 | -$0.64 | -- | -$8.07 | -$8.80 | -$9.48 | -$89.18 |
| **Diluted EPS** | -$0.85 | -$0.89 | -$0.64 | -- | -$8.07 | -$8.80 | -$9.48 | -$89.18 |
| Basic Shares Outstanding | 36.3M | 36.1M | 33.7M | -- | 1.5M | 1.5M | 1.5M | 178.5K |
| Diluted Shares Outstanding | 36.3M | 36.1M | 33.7M | -- | 1.5M | 1.5M | 1.5M | 178.5K |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 |
| --- | --- | --- |
| Cash & Cash Equivalents | $44.06M | $16.25M |
| Short-Term Investments | $105.1M | $55.78M |
| **Cash & Short-Term Investments** | $149.2M | $72.04M |
| **Total Current Assets** | $153.5M | $73.99M |
| Property, Plant & Equipment, Net | $994K | $1.33M |
| Long-Term Investments | $67.49M | -- |
| Other Non-Current Assets | $101K | $61K |
| **Total Non-Current Assets** | $71.47M | $2.07M |
| **Total Assets** | $224.9M | $76.06M |
| Accounts Payable | $7.76M | $8.26M |
| Deferred Revenue (Current) | -- | $3.00M |
| Other Current Liabilities | $364K | $573K |
| **Total Current Liabilities** | $17.91M | $27.98M |
| Other Non-Current Liabilities | -- | $535K |
| **Total Non-Current Liabilities** | $1.47M | $535K |
| **Total Liabilities** | $19.38M | $28.52M |
| **Total Debt (incl. Leases)** | $2.06M | $1.02M |
| Common Stock | $3.0K | $0 |
| Retained Earnings | -$221.1M | -$152.2M |
| **Total Stockholders' Equity** | $205.6M | -$144.2M |
| Total Equity | $205.6M | -$144.2M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $47.57M | $60.03M | $48.32M | $44.06M | $26.82M | $16.25M |
| Short-Term Investments | $121.1M | $140.8M | $163.1M | $105.1M | $49.24M | $55.78M |
| **Cash & Short-Term Investments** | $168.6M | $200.8M | $211.5M | $149.2M | $76.06M | $72.04M |
| **Total Current Assets** | $174.6M | $204.2M | $215.9M | $153.5M | $81.94M | $73.99M |
| Property, Plant & Equipment, Net | $1.63M | $1.65M | $1.64M | $994K | $970K | $1.33M |
| Long-Term Investments | $93.61M | $87.21M | $95.55M | $67.49M | -- | -- |
| Other Non-Current Assets | $42K | $66K | $73K | $101K | $61K | $61K |
| **Total Non-Current Assets** | $103.7M | $97.70M | $106.6M | $71.47M | $2.60M | $2.07M |
| **Total Assets** | $278.3M | $301.9M | $322.5M | $224.9M | $84.54M | $76.06M |
| Accounts Payable | $9.10M | $5.04M | $4.04M | $7.76M | $3.58M | $8.26M |
| Deferred Revenue (Current) | -- | -- | -- | -- | -- | $3.00M |
| Other Current Liabilities | $469K | $518K | $571K | $364K | $371K | $573K |
| **Total Current Liabilities** | $20.48M | $17.49M | $10.60M | $17.91M | $10.42M | $27.98M |
| Other Non-Current Liabilities | -- | -- | -- | -- | $261K | $535K |
| **Total Non-Current Liabilities** | $6.45M | $6.87M | $7.30M | $1.47M | $261K | $535K |
| **Total Liabilities** | $26.93M | $24.36M | $17.90M | $19.38M | $10.68M | $28.52M |
| **Total Debt (incl. Leases)** | $8.19M | $8.63M | $9.11M | $2.06M | $765K | $1.02M |
| Common Stock | $4.0K | $4.0K | $4.0K | $3.0K | $0 | $0 |
| Retained Earnings | -$305.9M | -$275.0M | -$242.8M | -$221.1M | -$192.8M | -$152.2M |
| **Total Stockholders' Equity** | $251.4M | $277.6M | $304.6M | $205.6M | -$183.1M | -$144.2M |
| Total Equity | $251.4M | $277.6M | $304.6M | $205.6M | -$183.1M | -$144.2M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 |
| --- | --- | --- |
| Net Income | -$68.87M | -$66.81M |
| Depreciation & Amortization | $600K | $500K |
| Stock-Based Compensation | $5.86M | $1.72M |
| Change in Payables | -$837K | $6.51M |
| **Operating Cash Flow** | -$76.44M | -$58.20M |
| Capital Expenditure | -$235K | -$88K |
| **Free Cash Flow** | -$76.68M | -$58.28M |
| Purchases of Investments | -$199.2M | -$90.25M |
| Sales & Maturities of Investments | $84.10M | $86.35M |
| **Investing Cash Flow** | -$115.3M | -$3.99M |
| **Financing Cash Flow** | $220.8M | $49.42M |
| **Net Change in Cash** | $29.02M | -$12.77M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Sep 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$30.88M | -$32.25M | -$21.67M | -$28.27M | -$12.47M | -$13.56M | -$14.56M | -$15.92M |
| Depreciation & Amortization | $200K | $200K | $100K | $100K | $100K | $200K | $200K | -- |
| Stock-Based Compensation | $4.42M | $4.60M | $3.45M | $4.20M | $560K | $556K | $544K | $401K |
| Change in Payables | $4.09M | $983K | -$3.75M | $3.85M | -$97K | -$3.90M | -$691K | -- |
| **Operating Cash Flow** | -$25.88M | -$20.32M | -$27.50M | -$16.70M | -$9.63M | -$26.21M | -$23.90M | -- |
| Capital Expenditure | -$233K | -$183K | -$83K | -$104K | -$131K | $0 | $0 | -- |
| **Free Cash Flow** | -$26.11M | -$20.50M | -$27.59M | -$16.80M | -$9.77M | -$26.21M | -$23.90M | -- |
| Purchases of Investments | -$47.53M | -$17.64M | -$108.8M | -$160.4M | -$38.77M | $0 | $0 | -- |
| Sales & Maturities of Investments | $61.08M | $49.12M | $23.50M | $37.60M | $15.00M | $18.00M | $13.50M | -- |
| **Investing Cash Flow** | $13.32M | $31.29M | -$85.36M | -$122.9M | -$23.91M | $18.00M | $13.50M | -- |
| **Financing Cash Flow** | $94K | $532K | $117.1M | $156.8M | -$274K | $64.34M | -$152K | -- |
| **Net Change in Cash** | -$12.46M | $11.51M | $4.25M | $17.25M | -$33.81M | $56.13M | -$10.55M | -- |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 |
| --- | --- | --- |
| **Operating Margin** | -623.6% | -1000.2% |
| **Net Profit Margin** | -529.8% | -954.4% |
| Return on Equity (ROE) | -33.5% | -- |
| Return on Assets (ROA) | -30.6% | -87.8% |
| Current Ratio | 8.57x | 2.64x |
| Quick Ratio | 8.33x | 2.57x |
| Debt to Equity | 0.01x | -- |
| **Revenue Growth (YoY)** | +85.7% | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Sep 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -- | -1018.9% | -899.9% | -623.6% | -- | -- | -- | -- |
| **Net Profit Margin** | -- | -946.7% | -759.9% | -529.8% | -- | -- | -- | -- |
| Return on Equity (ROE) | -45.0% | -34.1% | -25.0% | -33.5% | -- | -- | -- | -- |
| Return on Assets (ROA) | -40.6% | -31.4% | -23.6% | -30.6% | -- | -- | -- | -- |
| Current Ratio | 8.52x | 11.68x | 20.36x | 8.57x | 7.87x | -- | -- | -- |
| Quick Ratio | 8.23x | 11.48x | 19.94x | 8.33x | 7.30x | -- | -- | -- |
| Debt to Equity | 0.03x | 0.03x | 0.03x | 0.01x | -- | -- | -- | -- |
| **Revenue Growth (YoY)** | -100.0% | -- | -100.0% | -- | -- | -- | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
